Progenics Pharmaceuticals (PGNX) 8-K Changes in Registrant's Certifying Accountant

 EXHIBIT 16.1

March 16, 2012

Securities and Exchange Commission

100 F Street, N.E.

Washington, DC 20549

Commissioners:

We have read the statements made by Progenics Pharmaceuticals, Inc. (copy attached), which we understand will be filed with the Securities and Exchange Commission, pursuant to Item 4.01 of Form 8-K, as part of the Form 8-K of Progenics Pharmaceuticals, Inc. dated March 16, 2012. We agree with the statements concerning our Firm in such Form 8-K.

Very truly yours,

/s/ PricewaterhouseCoopers LLP